We are live on ! Find out more
CASM

CAS Medical Systems
CASM

Delisted

CASM was delisted on the 18th of April, 2019.

17 hedge funds and large institutions have $6.61M invested in CAS Medical Systems in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

168% more capital inflows, than outflows

Capital inflows: $412K | Capital outflows: $154K

0.72% more ownership

Funds ownership: 24.71% → 25.44% (+0.72%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

6% less funds holding

Funds holding: 18 → 17 (-1)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CASM Hedge Fund Activity: Q3 2017 in Review

17 of the 4,024 institutional investors tracked by Wall St. Rank reported a position in CAS Medical Systems (CASM) for Q3 2017, worth a combined $6.61M — down 18% from $8.08M a quarter earlier.

Fund positioning in CASM was balanced in Q3 2017: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 6 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $341K. The largest seller was Stonepine Capital Management, cutting an estimated $89.8K.

  • 17 institutional investors held CAS Medical Systems (CASM) as of Q3 2017, down from 18 in Q2 2017.
  • Funds reported $6.61M of CAS Medical Systems stock for Q3 2017, down 18% quarter-over-quarter.
  • 2 funds opened new CAS Medical Systems positions in Q3 2017 and 2 closed out, a net change of 0 holders.
  • The largest CAS Medical Systems buyer in Q3 2017 was Acuta Capital Partners, an estimated $341K added.
  • The largest CAS Medical Systems seller in Q3 2017 was Stonepine Capital Management, an estimated $89.8K sold.

Based on aggregated 13F filings for Q3 2017.